Annual revenue for the autoimmune disease diagnostics market from systemic disorders will witness a 3.9% CAGR through 2025, with technical developments in multiple autoantibodies screening tests to assist in the early diagnosis and treatment of the diseases. For instance, in October 2020, Amgen, a U.S. based pharma company, rolled-out a safety trial for the diagnostics to treat Systemic Lupus Erythematosus (SLE).
Global prevalence of systemic and localized autoimmune disorders, emergence of various government initiatives and enhanced ability to spend on the treatment of these ailments will stimulate autoimmune disease diagnostics market trends. The American Autoimmune Related Diseases Association (AARDA) revealed that over 50 million residents in the U.S. are diagnosed with autoimmune disorders, and this patient pool is likely to surge in the coming years.
Get sample copy of this research report @ https://www.decresearch.com/request-sample/detail/618
This factor is urging the growth of multiple strategies to tend to the treatment and the costs of these diseases. Also, the occurrence of autoimmune diseases is found to be 75% more in women as compared to men and is one of the top ten mortality factors for women in all age groups.
Market value from localized autoimmune disease diagnostics tests reached 66% of the total revenue share in 2018. This can be owed to the increased adoption of diagnostics kits and assays with the recurring incidences of autoimmune disorders like Hashimoto's thyroiditis, type 1 diabetes, and pernicious anemia in consumers. An increase in awareness across patients resulting from favorable government efforts will further boost product consumption.
U.S. recorded the highest demand for autoimmune disease diagnosis in the North American regional industry and contributed to a revenue close to USD 5 billion in 2018. The growth can be attributed towards the existence of sophisticated healthcare services and amenities in the country. There is also an incrementing awareness related to the advantages of early and accurate diagnosis of the diseases along with a higher healthcare spending capability of the regional population.
Service providers of autoimmune disease testing are keen on implanting various strategic decisions to enhance and expand their business portfolio to offer effective results in diagnostics, besides sustaining market competition. The currently active coronavirus pandemic has also significantly influenced the adoption of diagnostic tests and trials to a considerable extent.
Abbott Laboratories, BioMerieux SA, AESKU Diagnostics, Euroimmun, Inova diagnostics Inc, Bio-Rad Laboratories, Inc Siemens AG, Beckman Coulter Inc., SQI Diagnostics, and Quest Diagnostics are some of the prominent companies in the global autoimmune disease diagnostics market.
Request for a Customization of this research report @ https://www.decresearch.com/roc/618
Partial Chapter of the Table of Content
Chapter 4. Autoimmune Disease Diagnostics Market, By Product
4.1. Key segment trends
4.2. Systemic autoimmune disease diagnostics
4.2.1. Market estimates and forecast, by region, 2014 - 2025 (USD Million)
4.2.2. Rheumatoid arthritis diagnostics
184.108.40.206. Market estimates and forecast, by region, 2014 - 2025 (USD Million)
4.2.3. Ankylosing spondylitis diagnostics
220.127.116.11. Autoimmune Disease Diagnostics Market estimates and forecast, by region, 2014 - 2025 (USD Million)
4.2.4. Systemic lupus erythematosus diagnostics
18.104.22.168. Autoimmune Disease Diagnostics Market estimates and forecast, by region, 2014 - 2025 (USD Million)
22.214.171.124. Market estimates and forecast, by region, 2014 - 2025 (USD Million)
4.3. Localized autoimmune disease diagnostics
4.3.1. Market estimates and forecast, by region, 2014 - 2025 (USD Million)
Charts & Figures
FIG 1. Industry segmentation
FIG 2. Global autoimmune disease diagnostics market, 2014 – 2025 (USD Million)
FIG 3. Autoimmune disease incidence rate per 1,00,000 persons, 2012
FIG 4. Total autoimmune disease NIH funding, 2013 – 2018 (USD Million)
FIG 5. Growth potential analysis, by product
FIG 6. Porter’s analysis
FIG 7. Strategy dashboard
FIG 8. PESTEL analysis
Browse complete Table of Contents (ToC) of this research report @ https://www.decresearch.com/toc/detail/autoimmune-disease-diagnostics-market
Browse Related Report:
Protein A Resins Market Size 2026: Increasing government funding for cancer-related research may further bolster the demand for the substances. Protein A resins market size is forecast to surpass USD 1 billion by 2026 globally.Also, Germany being is one of the most developed countries in terms of technology and is spending hefty amounts for funding on R&D in biotechnology. Germany protein A resins market is likely to showcase growth rate of nearly 8.6% CAGR over the projected timeframe.